In 41 Gavi-eligible countries, in the absence of vaccine coverage, the number of Catastrophic Health Costs (CHC) cases caused by measles would be 18.9 million, by severe pneumococcal disease would be 6.6 million and by severe rotavirus disease would be 2.2 million. Expanding vaccine coverage in these countries would reduce the number of cases of CHC due to measles by 90%, due to pneumococcal disease by 30% and due to rotavirus disease by 40%.
Full Citation:
Riumallo-Herl, C., Chang, A.Y., Clark, S., et al.. 2018. Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus, and pneumococcal vaccines in low-income and middle-income countries: a modeling study. British Journal of Medicine Global Health. 3:e000612.
Title of Article: Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus, and pneumococcal vaccines in low-income and middle-income countries: a modeling study
Author(s): Riumallo-Herl, C., Chang, A.Y., Clark, S., et al.
Publication Year: 2018
Publication Name: British Journal of Medicine Global Health
Publication Volume: 3:e000612
Publication Source URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898318/
DOI (Digital Object Identifier): http://dx.doi.org/10.1136/bmjgh-2017-000613
Topics: Economics & Return on Investment
Disease Vaccines: Measles | Pneumococcal disease/PCV/PPSV | Rotavirus
Countries: Global